Marki Swick, MD
Dermatology · Brookfield, WINPI 1528562956
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $259 and has fallen 92.5% since, to $19 in 2025. That places this record below the midpoint for dermatology clinicians in WI, where the typical reported total is $365.
Across 26 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$65
- Johnson & Johnson$56
- LEO Pharma Inc.$50
- Boehringer Ingelheim$45
- Regeneron Healthcare Solutions, Inc.$45
- Dermavant Sciences, Inc.$32
- plus $154 from 8 others
What the payments were for
- Food & beverage$447100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 4 | $65 |
| Johnson & Johnson | 3 | $56 |
| LEO Pharma Inc. | 3 | $50 |
| Boehringer Ingelheim | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Dermavant Sciences, Inc. | 2 | $32 |
| Mylan Institutional Inc. | 2 | $30 |
| Novartis | 2 | $26 |
| Amgen | 1 | $22 |
| UCB, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
How this compares
$447 in reported general payments places this provider in the 50th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $258,584 |
| Dupixent PenDupilumab | 36 | $147,005 |
| ZoryveRoflumilast | 11 | $9,389 |
| Clobetasol Propionate | 201 | $7,779 |
| Ketoconazole | 334 | $5,503 |
| Fluorouracil | 54 | $4,534 |
| Triamcinolone Acetonide | 240 | $2,976 |
| Dutasteride | 88 | $2,277 |
| Metronidazole | 44 | $2,275 |
| Fluocinonide | 63 | $2,071 |
| Desonide | 61 | $1,864 |
| Tretinoin | 27 | $1,693 |
| Fluocinolone Acetonide | 32 | $1,568 |
| Doxycycline Monohydrate | 26 | $1,305 |
| Tacrolimus | 14 | $1,278 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Brookfield
- Kristina KlevenBrookfield$6K
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Kenneth GordonWauwatosa$577K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$232K
- Betsy WernliManitowoc$177K
- Daniel OpelSheboygan$118K
- Stephen LewellisPlover$73K
- Patrick SafoStevens Point$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.